Access to medicines

Access to medicines

One third of the world lacks  access to essential medicines.  In the poorest parts of Africa and Asia this figure rises to a half of the population. We challenge the high cost of medicines and the absence of treatment for many of the diseases affecting ou

Too often  we cannot treat patients because the medicines are too expensive, or they are no longer produced.  Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure. 
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases. 

 
Zipporah Wachira
Access to medicines

Beyond Borders: A Clinician's Journey in the Pearl of Africa

Article 7 Jun 2024
 
 Treating the COVID-19 Second wave
Access to medicines

MSF responds to the outcomes of PPR negotiations at WHA77

Article 5 Jun 2024
 
Halima is holding her daughter Aszed during vaccination
Access to medicines

Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines

Article 4 Jun 2024
 
Diphteria vaccination campaign in Batha Province, Chad
Access to medicines

As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination

Article 16 Apr 2024
 
 medicine for the treatment of drug resistant tuberculosis
Tuberculosis

Sierra Leone: New approach radically improves diagnosis and treatment of children with TB

Article 23 Mar 2024
 
MSF/Mohamed Adan
Epidemics

በአለም አቀፍ ደረጃ ለተከሰተውን የኮሌራ በሽታ ክትባት እጥረት መፍትሄ ሊሆን የሚችል የወረርሽኝ ምላሽ

Article 7 Mar 2024